Pharmex

What Pharmex does

Pharmex S.A. (ΦΑΡΜΕΞ ΑΝΩΝΥΜΗ ΤΕΧΝΙΚΗ ΚΑΙ ΤΟΥΡΙΣΤΙΚΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ) is a privately held Greek pharmaceutical company founded in 1981 and headquartered in Peristéri, Athens, operating as a subsidiary of the A.G.N. Papazoglou Group. The company runs a dual business model combining proprietary product development with exclusive distribution of international brands in the Greek market. Pharmex manufactures and markets its own pharmaceutical portfolio across dermatologicals (BETAFUSIN, BUDESODERM, BOTAFEX, OCTENISEPT, CIPOCAL), cardiovascular drugs (LARVIN, LORVATEN, PIDOLEN, VERITRAT), CNS agents (VESEMA), ophthalmologicals (GENTADEX, PHARDINOL), gastro-intestinal drugs (VAMAC), anti-infectives (MEROVIA), and musculoskeletal products (ENIMON), alongside proprietary consumer brands including the Helenvita dermocosmetics and food supplements line (rebranded in 2022 with new launches in March 2024) and the ophthalmic Helenvision line.

In parallel, Pharmex serves as the exclusive Greek distributor for several multinational brands: Eubos dermatological skincare (since 1981), Schülke & Mayr medical hygiene and anti-infection products (since 1988), Ursapharm ophthalmics (since 1994), and Dr Brown's baby care products (since 2006). Distribution flows through the Greek pharmacy channel to consumers and is recommended by pharmacists and dermatologists. The company holds ISO 9001:2015 and ISO 13485:2016 certifications and accesses EU-GMP-compliant manufacturing through partners.

Pharmex monetizes primarily through one-time sales of branded and distributed pharmaceutical and dermocosmetic products via the Greek pharmacy channel, supplemented by contract manufacturing revenue (notably the 2026 five-year agreement with Cosmos Health's Cana Laboratories covering ~2.86 million dermatological units) and product exports to more than 20 countries through commercial agents. Customer segments are Greek consumers, pharmacists, and dermatologists, with international reach extending across Europe, the Middle East, the Balkans, the Caucasus, Africa, Asia, and Latin America.

Name

Pharmex

Legal name

ΦΑΡΜΕΞ ΑΝΩΝΥΜΗ ΤΕΧΝΙΚΗ ΚΑΙ ΤΟΥΡΙΣΤΙΚΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ

Website

https://pharmex.gr

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

101–250 employees

Short description

Pharmex S.A. is a Greek pharmaceutical company (founded 1981, A.G.N. Papazoglou Group subsidiary) that develops proprietary Rx drugs, dermocosmetics, and food supplements and serves as the exclusive Greek distributor for international brands including Eubos, Schülke, Ursapharm, and Dr Brown's through the pharmacy channel.

Ownership category

akta.pro rank

Product category

Pharmaceutical Products

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Dermatology Specialty Pharmaceuticals (HLAIACAL)

akta.pro secondary industries

Ophthalmology Specialty Pharmaceuticals (HLAIACAK), Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Generic Hospital & Institutional Products (HLAIABAL), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Dermatological products
• Pharmaceutical manufacturing
• Dermocosmetics distribution
• Prescription medications
• Food supplements

Headquarters

HQ city

Peristéri

HQ country

Greece

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Proprietary Product Sales: Pharmex develops and sells its own branded dermocosmetics and food supplements under the Helenvita brand, as well as proprietary pharmaceutical products under brands such as BOTAFEX, BETAFUSIN, BUDESODERM, and others across dermatological, ophthalmological, cardiovascular, and other therapeutic categories.
2. Exclusive Distribution: Pharmex serves as the exclusive distributor in Greece for international brands including Dr Browns, Helenvita, Eubos, Schülke, and Helenvision, generating revenue through the resale of these branded products in the Greek market.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Pharmex S.A. develops, manufactures, and distributes proprietary pharmaceutical products (prescription and OTC drugs) covering dermatological, ophthalmological, cardiovascular, musculoskeletal, and CNS therapeutic areas, along with proprietary dermocosmetics and food supplements under the Helenvita brand and ophthalmic products under the Helenvision brand. The company additionally operates as the exclusive distributor in Greece for international brands including Eubos (dermocosmetics), Schülke (anti-infection products), Dr. Brown's (baby care), and Ursapharm (ophthalmics).

Product overview

Pharmex S.A. is a Greek pharmaceutical company founded in 1981, operating as one of the leading companies in medicinal products, dermocosmetics, and food supplements in Greece with over 40 years of experience. The company operates a dual business model: (1) Proprietary brands including Helenvita (dermocosmetics and food supplements with sub-lines for acne, sun care, mosquito protection, probiotics, vitamins, and urea skincare), Helenvision (ophthalmic products for dry eye and eye care), and its pharmaceutical drug portfolio covering dermatologicals (BETAFUSIN, BUDESODERM, BOTAFEX, OCTENISEPT, CIPOCAL), cardiovascular drugs (LARVIN, LORVATEN, PIDOLEN, VERITRAT), CNS drugs (VESEMA), ophthalmologicals (GENTADEX, PHARDINOL, PHARMEXIN), gastrointestinal drugs (VAMAC), anti-infectives (MEROVIA), and musculoskeletal drugs (ENIMON); (2) Exclusive distribution partnerships with international brands including Eubos (dermatologicals/cosmetics since 1981), Schülke (medical hygiene since 1988), Dr. Brown's (infant care since 2006), and others. The company manufactures at its EU-GMP certified Athens facility and distributes products across more than 20 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Helenvita: Innovative and high-quality dermocosmetic and food supplement products covering needs from infancy to adulthood, including women's beauty, men's grooming, and family health.
• Dr Brown's
• Eubos
• Schülke
• Helenvision

Products and services

• Helenvita Proprietary dermocosmetics and food supplements brand developed and distributed by Pharmex since 2005. Offers complete product lines covering needs from infancy to adolescence, women's beauty, men's grooming, and family health. Includes sub-lines for acne (Acnormal), sun care (SUN CARE), mosquito protection (Anti-Mosquito), probiotics (Probalance), vitamin C, and urea-based skincare.
• Helenvision Proprietary brand providing high-quality solutions for eye health and comfort through scientifically proven products for dry eye and broader ophthalmic needs. Features four core pillars: scientific precision, safety and high tolerance, effectiveness, and accessible everyday care.
• Eubos Dermatological and cosmetic brand with 80-year history, distributed exclusively in Greece by Pharmex. Known for pH-neutral, alkali-free body cleansers and comprehensive skincare products.
• Schülke Medical hygiene and anti-infection products brand distributed exclusively in Greece by Pharmex. Offers products for staff and patient protection, anti-infection and decontamination products from Schülke & Mayr.
• Dr. Brown's Infant care brand distributed exclusively in Greece by Pharmex. Offers baby bottles and feeding accessories designed to help raise strong and happy babies.
• BETAFUSIN (Betamethasone & Fusidic Acid Cream) Dermatological cream combining betamethasone and fusidic acid for treating inflammatory skin infections. Available in 2%+0.1% concentration in 15g and 30g tubes.
• BUDESODERM (Budesonide) Dermatological and cutaneous corticosteroid product containing budesonide for inflammatory skin conditions. Available as cream (0.025%, 50g) and cutaneous solution (0.025%, 30ml and 100ml).
• BOTAFEX (Minoxidil) Cutaneous solution for treating androgenetic alopecia and promoting hair growth. Available in 2% and 5% concentrations in 60ml bottles.
• OCTENISEPT Antiseptic cutaneous solution combining octenidine dihydrochloride and phenoxyethanol for wound disinfection and skin antisepsis. Available in 50ml, 250ml, and 1000ml bottles with spray systems.
• CIPOCAL (Calcipotriol) Vitamin D analog topical product for treating psoriasis. Available as cream and ointment (0.005% w/w) in 30g tubes.
• LARVIN (Clopidogrel) Antiplatelet agent for preventing blood clots in cardiovascular conditions. Film-coated tablets 75mg, pack of 28.
• LORVATEN (Atorvastatin) Statin medication for managing hypercholesterolemia and cardiovascular risk. Film-coated tablets available in 20mg and 40mg strengths, pack of 28.
• VESEMA (Citalopram) Selective serotonin reuptake inhibitor (SSRI) for treating depression. Film-coated tablets available in 20mg and 40mg, pack of 28.
• GENTADEX (Dexamethasone & Gentamicin) Ophthalmic combination product for treating eye inflammation with bacterial infection. Available as eye drops (0.1%+0.3%, 5ml) and eye ointment (0.3%+0.03%, 2.5g).
• PHARDINOL (Dorzolamide & Timolol) Ophthalmic product for glaucoma treatment combining carbonic anhydrase inhibitor and beta-blocker. Eye drops 2%+0.5% in 5ml vial.
• VAMAC (Omeprazole) Proton pump inhibitor for treating gastric acid-related disorders. Gastro-resistant hard capsules 20mg, pack of 28.
• MEROVIA (Meropenem) Broad-spectrum carbapenem antibiotic for serious bacterial infections. Powder for injection/infusion solution 1000mg per vial, pack of 10 vials.
• PIDOLEN (Amlodipine) Calcium channel blocker for hypertension and angina treatment. Hard capsules available in 5mg and 10mg strengths, pack of 30.
• VERITRAT (Simvastatin) Statin medication for hyperlipidemia management. Film-coated tablets 40mg, pack of 30.
• ENIMON (Alendronic Acid) Bisphosphonate for treating osteoporosis. Tablets 70mg, pack of 4.

Named customers3 records

Segments2 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core.

• Cosmos Health Inc. (Cana Laboratories S.A.)coreStrategic or Co-development Partner · 17 June 2026Pharmex S.A. entered into a five-year contract manufacturing agreement with Cosmos Health's wholly-owned subsidiary Cana Laboratories S.A. to produce approximately 2.86 million units of three dermatological pharmaceutical products at Cana's EU-GMP-licensed, EMA-certified facility in Greece. The agreement covers BETAFUSIN (2.25 million units), BOTAFEX (325,000 units), and BUDESODERM (285,000 units), supporting higher utilization of Cana's European manufacturing capacity and generating recurring revenue for Pharmex from higher-margin contract manufacturing activities.
• EuboscoreChannel Partner/ Reseller/ DistributorPharmex has been the exclusive distributor of Eubos products in Greece since 1981. Eubos is a dermocosmetics brand with 80 years of history in beauty and health, known for its pH-neutral, alkali-free, skin-compatible body cleansers.
• Schülke & MayrcoreChannel Partner/ Reseller/ DistributorPharmex has been the exclusive distributor of Schülke products in Greece since 1988. Schülke & Mayr supplies a full range of products for the protection of staff and patients, including anti-infection and decontamination products.
• UrsapharmcoreChannel Partner/ Reseller/ DistributorPharmex has been the exclusive distributor of Ursapharm products in Greece since 1994.
• Dr Brown'scoreChannel Partner/ Reseller/ DistributorPharmex has been the exclusive distributor of Dr Brown's products in Greece since 2006. Dr Brown's offers a full line of baby products including bottles and accessories designed to help raise strong and happy babies.
• HelenvisioncoreChannel Partner/ Reseller/ DistributorHelenvision is an eye health and comfort brand distributed by Pharmex in Greece, offering scientifically proven products for dry eye and broader ophthalmic needs, addressing prevention, relief, and comprehensive eye care at every age and life stage.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Almirall S.A. European specialty pharmaceutical company focused on dermatology. Comparable as a broader European specialty pharma incumbent with overlapping dermatology therapeutic categories (e.g., corticosteroids, psoriasis, acne).
• Galderma S.A. Global dermatology-focused pharmaceutical and skincare company covering prescription dermatology and aesthetic/consumer skincare. Comparable to Pharmex as a broad incumbent operating across both pharmaceutical and dermocosmetic dermatology categories, but at vastly greater scale.
• STADA Arzneimittel AG: European specialty pharmaceutical and generics company with strong consumer healthcare/dermocosmetics and generics portfolio. Comparable to Pharmex's hybrid model of branded generics plus consumer health products distributed via pharmacy channel.
• LEO Pharma A/S: Global dermatology specialty pharmaceutical company. Comparable as a broad incumbent in the dermatology pharmaceutical space with overlapping indications (psoriasis, eczema, skin infections).

Direct peers

• Viofar Ltd. Greek pharmaceutical company with branded generics across dermatology, ophthalmology, and other therapeutic areas. Directly comparable in product mix and Greek-market distribution orientation.
• ELPEN Pharmaceutical Co. Inc. Greek pharmaceutical manufacturer focused on generics and specialty pharmaceuticals across respiratory, cardiovascular, and CNS. Directly comparable to Pharmex as another Greek pharma producer-distributor with proprietary branded generics and export activities.
• Vianex S.A. One of the largest Greek pharmaceutical manufacturers with branded generics, OTC, and contract manufacturing capabilities. Comparable to Pharmex in operating a Greek pharma manufacturing and distribution business with international reach.
• Lavipharm S.A. Greek pharma and personal-care company with branded generics, dermocosmetics, and contract manufacturing operations. Closely comparable to Pharmex's mix of Rx pharmaceuticals, dermocosmetics, and third-party manufacturing.
• Famar S.A. Greek-headquartered contract development and manufacturing organization (CDMO) serving dermatology and pharmaceutical clients. Comparable to Pharmex's manufacturing side, particularly given the contract manufacturing relationship between Pharmex and Cana Laboratories (a peer in the same Greek pharma services ecosystem).

Regional players

• Ursapharm Arzneimittel GmbH: German ophthalmic pharmaceutical company and one of Pharmex's exclusive distribution principals in Greece. Comparable in ophthalmology product portfolio and serves as both a partner and an adjacent reference point for the Helenvision ophthalmology brand strategy.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/pharmex.gr
• LinkedInlinkedin.com/company/pharmex

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmex